ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Viva Biotech Holdings ?
1
High Debt company with Weak Long Term Fundamental Strength
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 1.66% signifying low profitability per unit of shareholders funds
2
Flat results in Jun 25
- CASH AND EQV(HY) Lowest at HKD 1,024.68 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 4.21 times
- NET SALES(Q) Lowest at HKD 893.56 MM
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Viva Biotech Holdings for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Viva Biotech Holdings
12.57%
3.09
80.55%
Hang Seng Hong Kong
8.25%
0.41
19.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
36.46%
EBIT Growth (5y)
29.19%
EBIT to Interest (avg)
1.98
Debt to EBITDA (avg)
2.22
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.33
Tax Ratio
24.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
4.47%
ROE (avg)
1.66%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.42
EV to EBIT
24.32
EV to EBITDA
12.60
EV to Capital Employed
1.39
EV to Sales
2.81
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
5.72%
ROE (Latest)
4.24%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at 5.67 %
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -15.23% (YoY
OPERATING PROFIT MARGIN(Q)
Highest at 26.84 %
NET PROFIT(Q)
Highest at HKD 81.93 MM
-4What is not working for the Company
CASH AND EQV(HY)
Lowest at HKD 1,024.68 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 4.21 times
NET SALES(Q)
Lowest at HKD 893.56 MM
Here's what is working for Viva Biotech Holdings
Debt-Equity Ratio
Lowest at 5.67 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Profit Margin
Highest at 26.84 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Net Profit
Highest at HKD 81.93 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Raw Material Cost
Fallen by -15.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Viva Biotech Holdings
Net Sales
Lowest at HKD 893.56 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Cash and Eqv
Lowest at HKD 1,024.68 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 4.21 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
